Nabumetone
Product Images NDC 33261-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 33261-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Nabumetone Tab 500mg For Watson 1)

FDA Label Image

6mna (Nabumetone Tab 500mg For Watson 2)

FDA Label Image

Figure (Nabumetone Tab 500mg For Watson 3)

Figure (Nabumetone Tab 500mg For Watson 3)
This is a graph or chart showing the progression of time in hours from 0 to 70, with markings every 5 units. It appears to be related to some kind of data or experiment, but without further information it is impossible to determine exactly what it represents.*
FDA Label Image

Image Label (Nabumetone Tab 500mg For Watson 4)

Image Label (Nabumetone Tab 500mg For Watson 4)
This is a description of a medication called Nabumetone produced by AIDAREX PHARMACEUTICALS LLC. Each tablet contains 500mg of Nabumetone and is available in a bottle of 90 tablets. The tablets are oval and white in color with "70" imprinted on one side of the tablet. Nabumetone is a generic alternative for the medication known as Relafen. The medication is manufactured by WATSON PHARMA PRIVATE LTD. in India. The dosage and administration instructions are not clear due to the text quality.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.